InsiderClue
Insiders · Profile

Svoronos Dawn

Director at Xenon Pharmaceuticals · Director at PTC THERAPEUTICS. Filing since 23 May 2017. CIK 0001574579

XENE Xenon Pharmaceuticals Inc. Director · 2 trades PTCT PTC THERAPEUTICS, INC. Director · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
XENE Xenon Pharmaceuticals Inc.
24 Aug 2023
Director
Sold at will
25,000
$967.50K
50.0%
PTCT PTC THERAPEUTICS, INC.
9 Jun 2022
Director
Sold, plan not stated
738
$20.07K
2.5%
PTCT PTC THERAPEUTICS, INC.
7 Jan 2022
Director
Sold, plan not stated
510
$19.65K
1.9%
PTCT PTC THERAPEUTICS, INC.
9 Jun 2021
Director
Sold, plan not stated
365
$15.29K
1.3%
PTCT PTC THERAPEUTICS, INC.
1 Feb 2021
Director
Sold, plan not stated
506
$28.82K
1.8%
PTCT PTC THERAPEUTICS, INC.
11 Jun 2020
Director
Sold, plan not stated
364
$17.60K
1.4%
XENE Xenon Pharmaceuticals Inc.
14 Aug 2017
Director
Bought
50,000
$140.77K
opened
PTCT PTC THERAPEUTICS, INC.
23 May 2017
Director
Bought
25,000
$337.23K
opened
8 decisions on file.